BRENNEN

Industries / Health / Healthcare / Pharmacy

Compounding

Compounding is mixing a medicine to order, such as a child's liquid dose or a bag of chemotherapy, when no factory-made product fits the patient.

7

Milestones achieved, from 2004 to 2025.

2

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 2004

    A standard for sterile mixing

    Compounding fell from 75% of US prescriptions in the 1930s to 1% by 1970, while hospital compounding grew with chemotherapy and intravenous feeding. The United States Pharmacopeia, which sets quality standards for drugs, introduced General Chapter 797 in 2004 for compounded sterile preparations, meaning medicines such as injections that must be free of germs. By 2012 it was described as the standard for sterile compounding in the United States. A 2016 comparison of FDA inspection reports found no link between a state requiring compliance with the chapter and the problems inspectors recorded.

    LessonA written standard does little until someone inspects against it.

    pmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov

    Credit

    United States Pharmacopeia

  2. 2006

    A child's chemotherapy bag

    Emily Jerry, aged 2, died in 2006 at Rainbow Babies & Children's Hospital in Cleveland after a pharmacy technician made up her chemotherapy with 23.4% sodium chloride in place of a standard bag holding less than 1%. The pharmacist who approved the bag, Eric Cropp, pleaded no contest to involuntary manslaughter and was sentenced in 2009 to six months in jail. Ohio had no registration or training requirements for technicians at the time. It then passed Emily's Law, which set licensing and minimum education requirements for them.

    LessonOne pharmacist's final look is a thin defense when the person mixing is untrained.

    medcitynews.comemilyjerryfoundation.org

    Credit

    Emily Jerry Foundation; Ohio legislature

  3. 2012

    Contaminated steroid injections

    In September 2012 US health officials began investigating fungal infections in patients injected with a steroid, preservative-free methylprednisolone acetate, bought from one compounding pharmacy, the New England Compounding Center. Three lots were recalled, and unopened vials were later found to hold fungus. 13,534 people may have been exposed. The CDC's final count, in October 2015, was 753 cases in 20 states and 64 deaths.

    LessonA pharmacy whose vials reach patients in 20 states works at a factory's scale and needs a factory's oversight.

    archive.cdc.govpubmed.ncbi.nlm.nih.gov

    Credit

    US Centers for Disease Control and Prevention and state health departments

  4. 2012

    A robot, measured

    Observers at a Boston academic hospital pharmacy watched 1,421 cancer-drug doses prepared by hand and 972 prepared by a robot. Serious medication errors were 0.7% in both periods. Doses that failed a weight-based accuracy check fell from 12.5% to 0.9%, and events that put staff at risk fell from 5.1% to 2.9%. Preparation time rose by 47%.

    LessonThe robot was more accurate and slower, and it did not cut serious errors.

    pubmed.ncbi.nlm.nih.gov

    Credit

    A. C. Seger and colleagues, Brigham and Women's Hospital

  5. 2013

    Two kinds of compounder

    The US Drug Quality and Security Act, enacted on 27 November 2013 in response to the 2012 outbreak, split compounders in two. A pharmacy under section 503A compounds for a named patient's prescription and is exempt from FDA approval and factory manufacturing rules. An "outsourcing facility" under the new section 503B may make batches without named patients, but must follow those manufacturing rules and is inspected by the FDA. The act also removed advertising limits in the 1997 law that the Supreme Court had struck down in 2002.

    fda.govpmc.ncbi.nlm.nih.gov

    Credit

    US Congress; FDA

  6. 2018

    Cancer drugs watered down

    In July 2018 the regional court in Essen, Germany, sentenced a pharmacist from Bottrop to 12 years in prison and a lifelong ban from the profession for underdosing cancer medicines he prepared between 2012 and 2016, at least 14,500 preparations. Two of his employees exposed him. Germany's Federal Court of Justice upheld the sentence in July 2020.

    LessonA compounded dose is taken on the maker's word unless someone tests it.

    aerzteblatt.de

    Credit

    two employees of the pharmacy; Essen regional court

  7. 2025

    A shortage ends, copying stops

    US compounders may not routinely make what is essentially a copy of a drug on sale, but conditions tied to the FDA's shortage list open the way while a drug is short. Semaglutide injections, used for diabetes and weight loss, were on the list from 2022, and compounders supplied copies. The FDA declared the tirzepatide shortage resolved on 19 December 2024 and the semaglutide shortage resolved on 21 February 2025. A federal court in Texas refused to block either decision, on 5 March and 24 April 2025, and the FDA's grace period for outsourcing facilities making semaglutide ran out on 22 May 2025.

    LessonA business built on a shortage ends when the shortage does.

    fda.gov

    Credit

    FDA; US District Court for the Northern District of Texas

Watch for

  1. Printed tablets in the pharmacy

    A Dutch group built a printer that squeezes a paste through a nozzle to build up each tablet, and a step-by-step way to validate it inside a hospital pharmacy. After two days of training, pharmacy staff printed placebo tablets that met European Pharmacopoeia limits on weight variation. The paper describes the steps still needed before printed tablets can be dispensed.

    Achieved whentablets holding an active drug are printed for patients as routine work, and an outside laboratory or inspector confirms their content.

    pubmed.ncbi.nlm.nih.gov

    Claimed by

    E. van Kampen and colleagues, Erasmus MC, with TNO and Maasstad Hospital, September 2026

  2. A robot fills 22,000 syringes

    Cleveland Clinic reports that a robotic syringe-filling device in its sterile cleanroom went from 5,290 syringes in its first month to an average of 22,640 a month by the end of its first year. Staffing fell from about 2.5 full-time workers for manual syringes and robot-made bags to 1.7 for both robots. The summary gives output and staffing, not error or contamination rates.

    Achieved whenan outside group measures dose accuracy and contamination for the robot against manual filling.

    pubmed.ncbi.nlm.nih.gov

    Claimed by

    T. Rice and colleagues, Cleveland Clinic, August 2026

Open

  1. 01

    A shared syringe-reading test

    A public set of photos and short videos of syringes filled with plain water to known volumes, each volume confirmed by weighing, with a scoring script, so that any camera-based checker or vision model can be scored on reading the volume drawn up. Water only; nothing is made for a person.

    The brief
    Credit · unclaimed
  2. 02

    Compounding harms since 2020

    A public, running table of US illnesses, deaths and recalls tied to compounded medicines from 2020 on, in the columns Pew used (year, cases, deaths, error, product, states), built from FDA alerts, FDA recall data and CDC and state reports, with a source link on every row.

    The brief
    Credit · unclaimed

Open 01 · the brief

A shared syringe-reading test

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public set of photos and short videos of syringes filled with plain water to known volumes, each volume confirmed by weighing, with a scoring script, so that any camera-based checker or vision model can be scored on reading the volume drawn up. Water only; nothing is made for a person.

Why it is still open

Camera checkers are sold, but each hospital tests its own. When Hôpital Beaujon in Clichy, France, qualified the DrugCam video system, volume recognition had 86% sensitivity, reading errors passed ±5% for small volumes, and some false positives could have released a wrong preparation. Its pharmacists wrote that no recommended qualification method exists for this type of equipment. The makers' own 2016 test reported a 2.1% error rate in reading syringe graduations. A web search found no documented open image set.

pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov

Built with what exists

Syringes from 1 mL to 60 mL in common brands; a laboratory balance, since 1 mL of water weighs about 1 g; a phone and a fixed camera; vision models run locally through llama.cpp (see the Note "A first stable number for local AI") and hosted models through their APIs; Label Studio for labeling.

  1. First step

    Buy 1 mL, 5 mL and 20 mL syringes, weigh 30 water fills of each, photograph them, and try one vision model.

  2. Done looks like

    At least 3,000 images across 6 syringe sizes, 3 brands and 2 lighting set-ups, with gloved hands in frame, each with its weighed volume. For at least three models, the share of readings within ±5%, reported separately for volumes under 0.2 mL. The set released under an open license.

Open 02 · the brief

Compounding harms since 2020

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public, running table of US illnesses, deaths and recalls tied to compounded medicines from 2020 on, in the columns Pew used (year, cases, deaths, error, product, states), built from FDA alerts, FDA recall data and CDC and state reports, with a source link on every row.

Why it is still open

Pew's drug safety project listed 73 compounding errors or potential errors from 2001 to 2019, linked to more than 1,562 adverse events and at least 116 deaths. Its last table is dated March 2020. An academic review covered published cases from 1990 to 2020 and found 63 errors. A search found no successor to either. Pew also noted that only 13 of 43 states surveyed required sterile compounders to report serious adverse events.

pewtrusts.orgpmc.ncbi.nlm.nih.gov

Built with what exists

The FDA's compounding risk alerts page; the openFDA drug enforcement API, which returned 1,832 recall records mentioning sterility dated from 1 January 2020 to 19 November 2026, from manufacturers as well as compounders; a language model through an API to read each notice into the table's columns, with a person checking every row; a public spreadsheet or code repository.

fda.gov

  1. First step

    Pull 2020's recall records from openFDA, keep the firms that appear on the FDA's list of registered outsourcing facilities, and match them against the FDA's alerts for that year.

  2. Done looks like

    Every FDA compounding alert and every compounder recall from 2020 through 2026 in one table with source links, and counts of events, cases and deaths for each year. A second person re-checks a random 10% of rows, and the disagreement rate is published.